Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL

被引：17
|
作者：
Frick, Mareike [1 ,2 ,3 ]
Bettstetter, Marcus [4 ]
Bertz, Simone [5 ]
Schwarz-Furlan, Stephan [5 ,6 ]
Hartmann, Arndt [5 ]
Richter, Thomas [7 ]
Lenze, Dido [8 ]
Hummel, Michael [8 ]
Dreyling, Martin [9 ]
Lenz, Georg [10 ,11 ]
Gaumann, Andreas [6 ]
机构：
[1] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[2] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany
[3] BIH Biomed Innovat Acad, Berlin Inst Hlth BIH, Berlin, Germany
[4] Mol Pathol Sudbayern, Munich, Germany
[5] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany
[6] Klinikum Kaufbeuren, Inst Pathol, Kaufbeuren, Germany
[7] Inst Pathol, Rosenheim, Germany
[8] Charite, Dept Pathol, Berlin, Germany
[9] Univ Hosp Munich, Dept Internal Med 3, Munich, Germany
[10] Univ Hosp Munster, Dept Med A, Translat Oncol, Munster, Germany
[11] Cluster Excellence EXC 1003, Cells Mot, Munster, Germany
来源：
LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 05期
基金：
瑞士国家科学基金会;
关键词：
B-CELL LYMPHOMA; ONCOGENIC MYD88; HIGH PREVALENCE; CLASSIFICATION; SURVIVAL;
D O I：
10.1080/10428194.2017.1370546
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1260 / 1263
页数：4
相关论文
共 50 条
  • [1] High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma
    Kraan, W.
    van Keimpema, M.
    Horlings, H. M.
    Schilder-Tol, E. J. M.
    Oud, M. E. C. M.
    Noorduyn, L. A.
    Kluin, P. M.
    Kersten, M. J.
    Spaargaren, M.
    Pals, S. T.
    LEUKEMIA, 2014, 28 (03) : 719 - 720
  • [2] High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma
    W Kraan
    M van Keimpema
    H M Horlings
    E J M Schilder-Tol
    M E C M Oud
    L A Noorduyn
    P M Kluin
    M J Kersten
    M Spaargaren
    S T Pals
    Leukemia, 2014, 28 : 719 - 720
  • [3] Consequences of CD79B and MYD88 mutations for B cell tolerance and lymphomagenesis
    Wang, J. Q.
    Batchelor, E.
    Kaya, S.
    Goodnow, C. C.
    Horikawa, K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 804 - 805
  • [4] Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
    Nakamura, T.
    Tateishi, K.
    Niwa, T.
    Matsushita, Y.
    Tamura, K.
    Kinoshita, M.
    Tanaka, K.
    Fukushima, S.
    Takami, H.
    Arita, H.
    Kubo, A.
    Shuto, T.
    Ohno, M.
    Miyakita, Y.
    Kocialkowski, S.
    Sasayama, T.
    Hashimoto, N.
    Maehara, T.
    Shibui, S.
    Ushijima, T.
    Kawahara, N.
    Narita, Y.
    Ichimura, K.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2016, 42 (03) : 279 - 290
  • [5] High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma
    Schrader, Anne M. R.
    Jansen, Patty M.
    Willemze, Rein
    Vermeer, Maarten H.
    Cleton-Jansen, Anne-Marie
    Somers, Sebastiaan F.
    Veelken, Hendrik
    van Eijk, Ronald
    Kraan, Willem
    Kersten, Marie Jose
    van den Brand, Michiel
    Stevens, Wendy B. C.
    de Jong, Daphne
    Hamid, Myrurgia Abdul
    Tanis, Bea C.
    Posthuma, Eduardus F. M.
    Nijland, Marcel
    Diepstra, Arjan
    Pals, Steven T.
    Cleven, Arjen H. G.
    Vermaat, Joost S. P.
    BLOOD, 2018, 131 (18) : 2086 - 2089
  • [6] Prevalence And Clinical Significance Of Oncogenic CD79B And MYD88 Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China
    Chen, Yan-ping
    Ke, Long-feng
    Lu, Jian-ping
    Wang, Jian-chao
    Zhu, Wei-feng
    Chen, Fang-fang
    Lin, Shao-feng
    Xu, Chun-wei
    Wu, Mei-juan
    Chen, Gang
    ONCOTARGETS AND THERAPY, 2019, 12 : 10165 - 10175
  • [7] Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations
    Kersten, M. J.
    Kraan, W.
    Doorduijn, J.
    Bromberg, J.
    Lam, K.
    Kluin, P. M.
    van der Holt, B. J.
    Spaargaren, M.
    Pals, S. T.
    BLOOD CANCER JOURNAL, 2014, 4 : e266 - e266
  • [8] MYD88, CD79B, and CD79A Gene Mutations in CD5-Positive Diffuse Large B-Cell Lymphoma
    Takeuchi, Toshifumi
    Yamaguchi, Motoko
    Kobayashi, Kyoko
    Miyazaki, Kana
    Imai, Hiroshi
    Ono, Ryoichi
    Tawara, Isao
    Nosaka, Tetsuya
    Tanaka, Kyosuke
    Katayama, Naoyuki
    BLOOD, 2016, 128 (22)
  • [9] Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations
    M J Kersten
    W Kraan
    J Doorduijn
    J Bromberg
    K Lam
    P M Kluin
    B J van der Holt
    M Spaargaren
    S T Pals
    Blood Cancer Journal, 2014, 4 : e266 - e266
  • [10] Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice
    Visco, Carlo
    Tanasi, Ilaria
    Quaglia, Francesca Maria
    Ferrarini, Isacco
    Fraenza, Costanza
    Krampera, Mauro
    CANCERS, 2020, 12 (10) : 1 - 15
12345